Author

Digambar Behera

Professor of Pulmonary Medicine, PGIMER Chandigarh - Cited by 11,475 - pulmonary medicine - respiratory medicine

Biography

Doctor Digambar Behera works in the Department of Pulmonary Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India a well-known researcher in the field of Public Health. One of his renowned works are coved-19 and Tuberculosis Control
Title
Cited by
Year
White paper on Ivermectin as a potential therapy for COVID-19
A Vora, VK Arora, D Behera, SK TripathyIndian journal of tuberculosis 67 (3), 448-451, 2020202
56
2020
Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis—report 1: guidelines for initiating antitubercular therapy in tubercular …
R Agrawal, I Testi, S Mahajan, YS Yuen, A Agarwal, OM Kon, ...Ophthalmology 128 (2), 266-276, 2021202
56
2021
Guidelines for diagnostic flexible bronchoscopy in adults: Joint Indian Chest Society/National College of chest physicians (I)/Indian association for bronchology recommendations
A Mohan, K Madan, V Hadda, P Tiwari, S Mittal, R Guleria, GC Khilnani, ...Lung India: Official Organ of Indian Chest Society 36 (Suppl 2), S37, 2019201
54
2019
Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis—report 2: guidelines for initiating antitubercular therapy in anterior …
R Agrawal, I Testi, B Bodaghi, T Barisani-Asenbauer, P McCluskey, ...Ophthalmology 128 (2), 277-287, 2021202
47
2021
Helsinki by nature: the nature step to respiratory health
T Haahtela, L Von Hertzen, JM Anto, C Bai, A Baigenzhin, ED Bateman, ...Clinical and translational allergy 9, 1-12, 2019201
42
2019
A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals
T To, G Viegi, A Cruz, L Taborda-Barata, I Asher, D Behera, K Bennoor, ...European Respiratory Journal 56 (1), 2020202
37
2020
TB control in India in the COVID era
D Beheraindian journal of tuberculosis 68 (1), 1-133, 2021202
28
2021
A real-world study of the dosing and tolerability of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis
S Dhooria, R Agarwal, IS Sehgal, KT Prasad, V Muth, M Garg, A Bal, ...Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 37 (2), 148, 2020202
21
2020
Role of CT chest and cytology in differentiating tuberculosis from presumed sarcoidosis in uveitis
R Bansal, A Gupta, R Agarwal, M Dogra, G Bhutani, V Gupta, MR Dogra, ...Ocular Immunology and Inflammation 27 (7), 1041-1048, 202
19
2019
Genetic investigation of polymorphic OGG1 and MUTYH genes towards increased susceptibility in lung adenocarcinoma and its impact on overall survival of lung cancer patients …
A Singh, N Singh, D Behera, S SharmaPathology & Oncology Research 25, 1327-1340, 2019201
14
2019
Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial
A Azuma, L Chung, D Behera, M Chung, Y Kondoh, T Ogura, M Okamoto, ...Respiratory Investigation 59 (2), 252-259, 2021202
13
2021
Tuberculosis, COVID-19, and the End Tuberculosis strategy in India
D BeheraLung India: Official Organ of Indian Chest Society 37 (6), 467, 2020202
11
2020
The collaborative ocular tuberculosis study (COTS) consensus (CON) group meeting proceedings
R Agrawal, I Testi, S Mahajan, YS Yuen, A Agarwal, A Rousselot, D Raje, ...Ocular immunology and inflammation 28 (sup1), 85-95, 2020202
10
2020
Underutilization of potential donors for lung transplantation at a tertiary care center in North India
KT Prasad, IS Sehgal, S Dhooria, V Muthu, R Agarwal, D Behera, ...Lung India: Official Organ of Indian Chest Society 36 (5), 399, 2019201
10
2019
Management of interstitial lung diseases: a consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP)
S Singh, BB Sharma, M Bairwa, D Gothi, U Desai, JM Joshi, D Talwar, ...Lung India: Official Organ of Indian Chest Society 37 (4), 359, 2020202
8
2020
Thyroid dysfunction in non-small cell lung cancer patients treated with epidermal growth factor receptor and anaplastic lymphoma kinase inhibitors: Results of a prospective cohort
S Soni, A Rastogi, KT Prasad, D Behera, N SinghLung cancer 151, 16-19, 2021202
8
2021
Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects
Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 309 subjectsS Dhooria, IS Sehgal, R Agarwal, V Muthu, KT Prasad, S Kathirvel, ...PLoS One 17 (7), e0271665, 2022202
8
2022
Elucidation of drug resistance mutations in Mycobacterium tuberculosis isolates from North India by whole-genome sequencing
S Sethi, Y Hao, SM Brown, T Walker, R Yadav, K Zaman, AN Aggarwal, ...Journal of global antimicrobial resistance 20, 11-15, 2020202
8
2020
Comparative evaluation of loop-mediated isothermal amplification (LAMP) assay, GeneXpert MTB/Rif and multiplex PCR for the diagnosis of tubercular lymphadenitis in HIV-infected …
N Baikunje, D Behera, A Rajwanshi, M Sharma, A Sharma, K SharmaMolecular and cellular probes 48, 101459, 2019201
7
2019
The multi-faceted high order polymorphic synergistic interactions among nucleotide excision repair genes increase the risk of lung cancer in North Indians
S Lawania, A Singh, S Sharma, N Singh, D BeheraMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 816 …, 2019201
7
2019

Referred From: https://scholar.google.com/citations?hl=en&user=58Q6vggAAAAJ

Cited by
Citations 11475
h-index 56
i10-index 251
Recommended Journals
Open Access Journals